Ionpath

Ionpath delivers high definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate discovery and improve human health. Ionpaths MIBITM (multiplexed ion beam imaging) Platform breaks through the limitations of traditional IHC, enabling deep understanding of the tissue microenvironment with highly multiplexed quantitative single-cell analysis. With MIBI technology and the expertise of world class pathology and data science teams, Ionpath provides actionable insights to translational and clinical researchers at leading pharma, biotech, and research organizations in immuno-oncology, immunology, neuroscience and infectious disease research

Mass spectrometry,pathology,cancer,neuroscience,mibi,spatial proteomics,immuno-oncology,multiplexed tissue imaging,translational research,autoimmune disease,and precision medicine

Ionpath operates in the Biotechnology research industry.

Ionpath's revenue is 11m - 100m

Ionpath has 11 - 50 employees.